About Concentric Analgesic
Concentric Analgesic is a company based in San Francisco (United States) founded in 2014 by John Donovan and Craig Husfeld.. Concentric Analgesic has raised $85.46 million across 4 funding rounds from investors including TD Securities, Oracle Investment Management and Venrock Capital Partners. Concentric Analgesic offers products and services including TRPV1 Agonist Prodrugs. Concentric Analgesic operates in a competitive market with competitors including Avidity Biosciences, Flexion Therapeutics, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter San Francisco, United States
- Founders John Donovan, Craig Husfeld
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Concentric Analgesics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$85.46 M (USD)
in 4 rounds
-
Latest Funding Round
$77.1 M (USD), Series B
May 21, 2019
-
Investors
TD Securities
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Concentric Analgesic
Concentric Analgesic offers a comprehensive portfolio of products and services, including TRPV1 Agonist Prodrugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides long-lasting non-opioid pain relief via single local injection.
Unlock access to complete
Unlock access to complete
Funding Insights of Concentric Analgesic
Concentric Analgesic has successfully raised a total of $85.46M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $77.1 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $77.1M
-
First Round
First Round
(06 Dec 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series B - Concentric Analgesic | Valuation | Oracle Investment Management | |
| Nov, 2018 | Amount | Debt – Conventional - Concentric Analgesic | Valuation |
investors |
|
| Dec, 2017 | Amount | Debt – Conventional - Concentric Analgesic | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Concentric Analgesic
Concentric Analgesic has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include TD Securities, Oracle Investment Management and Venrock Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & PE firm focused on healthcare sector
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by Kern Whelan Capital.
|
Founded Year | Domain | Location | |
|
Research-driven investment firm focused on global health care and bioscience sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Concentric Analgesic
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Concentric Analgesic
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Concentric Analgesic Comparisons
Competitors of Concentric Analgesic
Concentric Analgesic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Flexion Therapeutics, Univercells, Sutro Biopharma and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Concentric Analgesic
Frequently Asked Questions about Concentric Analgesic
When was Concentric Analgesic founded?
Concentric Analgesic was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Concentric Analgesic located?
Concentric Analgesic is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Concentric Analgesic?
Frank J Bellizzi is the current CEO of Concentric Analgesic.
Is Concentric Analgesic a funded company?
Concentric Analgesic is a funded company, having raised a total of $85.46M across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $5.35M, raised on Dec 06, 2016.
What does Concentric Analgesic do?
Concentric Analgesic was founded in 2014 in San Francisco, United States, and operates in the biotechnology sector focused on analgesics. A platform for the discovery and development of pro-drugs is maintained, emphasizing non-opioid options that aim to reduce opioid consumption. The lead candidate, CA-008, a water-soluble prodrug converting to capsaicin as a TRPV1 agonist, is currently in phase II clinical trials.
Who are the top competitors of Concentric Analgesic?
Concentric Analgesic's top competitors include Sutro Biopharma, Flexion Therapeutics and Avidity Biosciences.
What products or services does Concentric Analgesic offer?
Concentric Analgesic offers TRPV1 Agonist Prodrugs.
Who are Concentric Analgesic's investors?
Concentric Analgesic has 4 investors. Key investors include TD Securities, Oracle Investment Management, Venrock Capital Partners, and Kern Whelan Capital.